MYCOPHENILIC ACID vs TACROLIMUS OINTMENT 0.1%

Compare MYCOPHENILIC ACID (Mycophenolic Acid) and TACROLIMUS OINTMENT 0.1% (Tacrolimus) — clinical data, side effects, and patient experiences.

MYCOPHENILIC ACID

Mycophenolic Acid · Immunosuppressant

How it works

12.1 Mechanism of Action Mycophenolic acid (MPA), an immunosuppressant, is an uncompetitive and reversible inhibitor of inosine monophosphate dehydrogenase (IMPDH), and therefore i...

Approved for

See full prescribing information

OralTablet

TACROLIMUS OINTMENT 0.1%

Tacrolimus · Immunosuppressant

How it works

Other agent

Approved for

INDICATIONS AND USAGE Tacrolimus ointment

both 0.03% and 0.1% for adults

and only 0.03% for children aged 2 to 15 years

or when those treatments are not advisable. Tacrolimus ointment is not indicated for children younger than 2 years of age (see boxed WARNING

TopicalTablet

Quick Comparison

MYCOPHENILIC ACIDTACROLIMUS OINTMENT 0.1%

Drug Class

Immunosuppressant

Route

Oral

Topical

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

MYCOPHENILIC ACID

Drug Not Working

>10%

Diarrhea

1-10%

Fever

1-10%

Nausea

1-10%

Fatigue

0.1-1%

Headache

0.1-1%

Shortness of Breath

0.1-1%

TACROLIMUS OINTMENT 0.1%

Drug Not Working

>10%

Diarrhea

1-10%

Fever

1-10%

FDA Warnings

MYCOPHENILIC ACID

5 WARNINGS AND PRECAUTIONS New or Reactivated Viral Infections: Consider reducing immunosuppression
6 ) Serious GI Tract Complications (gastrointestinal bleeding, perforations and ulcers): Administer with caution to patients with active digestive system disease
1 Embryo-Fetal Toxicity Use of mycophenolic acid delayed-release tablets during pregnancy is associated with an increased risk of first trimester pregnancy loss and an increased risk of congenital malformations, especially external ear and other facial abnormalities, including cleft lip and palate, and anomalies of the distal limbs, heart, esophagus, kidney, and nervous system
Females of reproductive potential must be aware of these risks and must be counseled regarding pregnancy prevention and planning

TACROLIMUS OINTMENT 0.1%

WARNING Long-term Safety of Topical Calcineurin Inhibitors Has Not Been Established Although a causal relationship has not been established, rare cases of malignancy (e

Clinical Trial Data

No head-to-head clinical studies found for MYCOPHENILIC ACID vs TACROLIMUS OINTMENT 0.1%.

MYCOPHENILIC ACID vs TACROLIMUS OINTMENT 0.1%: What You Should Know

Key Differences

Both MYCOPHENILIC ACID and TACROLIMUS OINTMENT 0.1% belong to the Immunosuppressant class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients. MYCOPHENILIC ACID is administered via Oral, whereas TACROLIMUS OINTMENT 0.1% uses Topical. Route of administration can affect onset of action and patient adherence.

Safety Considerations

MYCOPHENILIC ACID carries 4 FDA warnings. TACROLIMUS OINTMENT 0.1% carries 1 FDA warning. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

EVEROLIMUS vs MYCOPHENILIC ACID→MYCOPHENILIC ACID vs SIROLIMUS→CYCLOSPORINE OPHTHALMIC SOLUTION vs MYCOPHENILIC ACID→CYCLOSPORINE vs MYCOPHENILIC ACID→AZATHIOPRINE vs MYCOPHENILIC ACID→MYCOPHENILIC ACID vs TACROLIMUS EXTENDED-RELEASE CAPSULES→

Loading comparison data...

MYCOPHENILIC ACID vs TACROLIMUS OINTMENT 0.1%

Compare MYCOPHENILIC ACID (Mycophenolic Acid) and TACROLIMUS OINTMENT 0.1% (Tacrolimus) — clinical data, side effects, and patient experiences.

MYCOPHENILIC ACID

Mycophenolic Acid · Immunosuppressant

How it works

12.1 Mechanism of Action Mycophenolic acid (MPA), an immunosuppressant, is an uncompetitive and reversible inhibitor of inosine monophosphate dehydrogenase (IMPDH), and therefore i...

Approved for

See full prescribing information

OralTablet

TACROLIMUS OINTMENT 0.1%

Tacrolimus · Immunosuppressant

How it works

Other agent

Approved for

INDICATIONS AND USAGE Tacrolimus ointment

both 0.03% and 0.1% for adults

and only 0.03% for children aged 2 to 15 years

or when those treatments are not advisable. Tacrolimus ointment is not indicated for children younger than 2 years of age (see boxed WARNING

TopicalTablet

Quick Comparison

MYCOPHENILIC ACIDTACROLIMUS OINTMENT 0.1%

Drug Class

Immunosuppressant

Route

Oral

Topical

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

MYCOPHENILIC ACID

Drug Not Working

>10%

Diarrhea

1-10%

Fever

1-10%

Nausea

1-10%

Fatigue

0.1-1%

Headache

0.1-1%

Shortness of Breath

0.1-1%

TACROLIMUS OINTMENT 0.1%

Drug Not Working

>10%

Diarrhea

1-10%

Fever

1-10%

FDA Warnings

MYCOPHENILIC ACID

5 WARNINGS AND PRECAUTIONS New or Reactivated Viral Infections: Consider reducing immunosuppression
6 ) Serious GI Tract Complications (gastrointestinal bleeding, perforations and ulcers): Administer with caution to patients with active digestive system disease
1 Embryo-Fetal Toxicity Use of mycophenolic acid delayed-release tablets during pregnancy is associated with an increased risk of first trimester pregnancy loss and an increased risk of congenital malformations, especially external ear and other facial abnormalities, including cleft lip and palate, and anomalies of the distal limbs, heart, esophagus, kidney, and nervous system
Females of reproductive potential must be aware of these risks and must be counseled regarding pregnancy prevention and planning

TACROLIMUS OINTMENT 0.1%

WARNING Long-term Safety of Topical Calcineurin Inhibitors Has Not Been Established Although a causal relationship has not been established, rare cases of malignancy (e

Clinical Trial Data

No head-to-head clinical studies found for MYCOPHENILIC ACID vs TACROLIMUS OINTMENT 0.1%.

MYCOPHENILIC ACID vs TACROLIMUS OINTMENT 0.1%: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.